Additional information
White powder
139481-72-4
ACI-032124
184.1-186.9°C
C43H34N6O3
682.77
cold Condition
-20°C
Hypertension
Pharmaceutical Impurity Standards
2-Ethoxy-1-[[2`-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1`-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (N-Trityl candesartan)
2-Ethoxy-1-[(2?-(1-trityl-1H-tetrazol-5-yl)-1,1?-biphenyl-4-yl)methyl]-7-benzimidazolecarboxylic acid Candesartan-trityl candesartan
Candesartan-trityl candesartan





![N-METHYL REGADENOSON (25 mg) (1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N,N-dimethylpyrazole-4-carboxamide )](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)